nipah
viru
niv
hendra
viru
hev
repres
highli
pathogen
zoonot
agent
paramyxoviru
genu
henipaviru
human
case
fatal
rate
rang
virus
categor
biosafeti
level
pathogen
due
signific
morbid
mortal
associ
diseas
lack
approv
vaccin
therapeut
human
use
primari
reservoir
henipavirus
bat
genu
pteropu
howev
virus
transmit
mani
mammalian
speci
includ
human
current
two
distinct
strain
niv
malaysia
strain
nivm
discov
outbreak
pig
farm
result
spread
human
bangladesh
strain
nivb
discov
india
bangladesh
nivb
link
direct
transmiss
bat
human
evid
suggest
human
human
transmiss
possibl
near
annual
outbreak
nivb
high
case
fatal
rate
underscor
urgent
need
effect
vaccin
therapeut
date
four
experiment
prevent
candid
vaccin
henipavirus
evalu
anim
model
vaccinia
canarypox
virus
encod
nivm
glycoprotein
shown
protect
nivm
hamster
pig
recombin
adenoassoci
vaccin
express
nivm
g
protein
complet
protect
hamster
homolog
nivm
challeng
protect
anim
heterolog
hev
infect
addit
recombin
subunit
vaccin
base
hev
g
protein
sghev
complet
protect
small
anim
lethal
hev
nivm
infect
recent
shown
efficaci
robust
african
green
monkey
model
nivm
infect
though
promis
sghev
vaccin
requir
primeboost
strategi
confer
protect
wherea
singleinject
vaccin
would
particularli
benefici
outbreak
littl
time
employ
lengthi
vaccin
regimen
singleinject
recombin
vesicular
stomat
viru
rvsv
vector
develop
vaccin
candid
mani
import
human
pathogen
papillomaviru
human
immunodefici
viru
hiv
influenza
viru
measl
viru
respiratori
syncyti
viru
sever
acut
respiratori
syndrom
coronaviru
chikungunya
viru
hemorrhag
fever
virus
lassa
ebola
marburg
singlecycl
replic
rvsv
develop
niv
shown
strong
immunogen
mice
vaccin
rvsv
express
either
nivm
fusion
protein
f
nivm
attach
protein
g
high
neutral
antibodi
titer
gener
vaccin
vector
recent
shown
provid
homolog
protect
hamster
model
nivm
infect
develop
altern
rvsv
vaccin
vector
express
either
nivb
f
nivb
g
protein
vaccin
evalu
day
singl
dose
vaccin
nivm
ferret
model
along
african
green
monkey
faith
recapitul
human
diseas
group
specif
vaccin
ferret
protect
nivminduc
diseas
nonspecif
vaccin
ferret
succumb
nivm
infect
date
first
studi
protect
ferret
niv
infect
use
singleinject
vaccin
investig
protect
efficaci
rvsv
nivb
vaccin
vector
heterolog
nivm
challeng
ferret
first
develop
recov
two
construct
express
nivb
f
protein
figur
blue
nivb
g
protein
figur
yellow
use
revers
genet
propag
vector
requir
vsv
glycoprotein
gind
complement
gind
virus
gind
provid
tran
infect
gind
complement
allow
singlecycl
replic
vector
result
express
nivb
glycoprotein
product
noninfecti
virion
contain
either
glycoprotein
seen
previous
similar
nivm
rvsv
vector
coinfect
gind
gind
produc
infecti
virion
contain
either
genom
nivb
f
nivb
g
protein
incorpor
virion
envelop
figur
group
greenspik
virion
evidenc
abil
viru
prepar
infect
vero
cell
figur
inabl
infect
cell
without
gind
complement
neg
data
shown
viru
stock
abl
reach
titer
pfuml
infect
vero
cell
stock
result
syncytia
format
figur
vaccin
prepar
could
undergo
singl
round
replic
could
passag
without
gind
complement
observ
vaccin
prepar
four
group
ferret
figur
receiv
singl
vaccin
rvsv
vector
follow
group
serv
nonspecif
vaccin
control
group
receiv
gind
group
receiv
gind
rvsvnivbfgfp
group
receiv
gind
rvsvnivb
ggfp
group
receiv
figur
triangl
serum
collect
anim
day
vaccin
day
challeng
day
analyz
circul
igg
niv
f
niv
g
protein
microspher
assay
expect
detect
niv
fspecif
ig
sera
vaccin
figur
day
abl
detect
ig
direct
niv
f
sera
group
vaccin
cohort
day
vaccin
ferret
group
figur
day
similar
analysi
niv
fspecif
circul
igg
vaccin
ferret
unabl
detect
igg
direct
niv
g
vaccin
figur
day
abl
detect
antiniv
g
igg
day
post
vaccin
figur
day
anim
group
higher
level
circul
antiniv
g
igg
compar
group
surprisingli
abl
detect
antiniv
g
igg
group
anim
although
level
nivb
gspecif
vaccin
group
anim
figur
day
result
suggest
anim
group
group
gener
humor
immun
respons
antigen
deliv
singl
inject
determin
whether
vaccin
vector
could
prevent
nivm
diseas
cours
ferret
challeng
ferret
intranas
lethal
challeng
dose
nivm
day
figur
anim
close
monitor
cours
day
post
challeng
pc
clinic
sign
ill
specif
vaccin
anim
group
lose
weight
cours
studi
figur
protect
nivm
figur
anim
nonspecif
vaccin
group
succumb
infect
day
figur
respect
figur
tabl
clinic
score
record
day
challeng
anim
use
score
system
base
coat
groom
social
behavior
provok
behavior
clinic
score
anim
correl
surviv
data
seen
mean
clinic
score
anim
vaccin
group
score
day
pc
versu
anim
group
clinic
score
day
pc
clinic
sign
respons
nivb
infect
dramat
anim
group
compar
anim
three
group
tabl
anim
succumb
nivm
infect
gross
patholog
find
includ
vari
sever
dehydr
ventral
cervic
subcutan
hemorrhag
edema
figur
crust
serou
nasal
discharg
figur
intern
gross
patholog
find
anim
group
includ
vari
sever
heavi
wet
diffus
mottl
dark
pin
point
foci
throughout
pulmonari
parenchyma
multifoc
pin
point
rais
foci
throughout
renal
parenchyma
mottl
spleen
diffus
splenomegali
diffus
reticul
liver
anim
diffus
hemorrhag
interstiti
pneumonia
figur
splenomegali
multifoc
necrosi
pic
addit
diffus
reticul
liver
figur
multifoc
renal
hemorrhag
figur
arrow
note
extern
intern
gross
patholog
find
note
group
anim
studi
endpoint
figur
day
tissu
examin
anim
group
signific
histolog
find
figur
e
devoid
niv
antigen
figur
f
j
n
contrast
tissu
examin
ferret
control
group
substanti
histolog
find
includ
mild
moder
interstiti
pneumonia
mark
congest
endotheli
syncyti
cell
format
respiratori
epitheli
syncyti
cell
format
figur
arrow
head
sever
lymphoid
deplet
necrosi
hemorrhag
fibrin
deposit
syncyti
cell
format
observ
throughout
spleen
figur
glomerular
tuft
kidney
multifoc
segment
global
fibrin
deposit
endotheli
syncyti
cell
format
figur
ferret
control
group
also
detect
niv
antigen
system
endothelium
scatter
mononuclear
cell
syncyti
cell
endotheli
epitheli
lung
figur
spleen
figur
kidney
figur
brain
figur
strong
immunolabel
niv
antigen
determin
nivm
replic
anim
pc
viremia
assess
viru
isol
serum
neg
data
shown
qrtpcr
whole
blood
sampl
figur
nivm
genom
equival
geq
detect
blood
sampl
day
pc
detect
nivm
geq
anim
day
group
anim
fold
detect
geq
increas
geq
termin
bleed
day
figur
howev
none
specif
vaccin
anim
detect
nivm
rna
termin
blood
sampl
day
figur
nivm
rna
also
detect
system
tissu
anim
succumb
infect
control
group
spleen
one
anim
group
studi
end
date
figur
though
nivm
antigen
detect
immunohistochemistri
data
shown
wherea
nivm
rna
detect
tissu
remain
anim
group
addit
abl
isol
nivm
tissu
sampl
anim
control
group
except
liver
anim
figur
overal
level
detect
nivm
rna
tissu
blood
correl
outcom
gross
patholog
histolog
figur
figur
tabl
anim
address
antibodi
respons
vaccin
nivm
challeng
character
circul
antibodi
vaccin
neutral
activ
use
plaqu
reduct
neutral
titer
assay
four
group
lack
neutral
antibodi
titer
vaccin
figur
day
challeng
anim
control
group
neutral
antibodi
titer
nivm
wherea
ferret
group
neutral
antibodi
nivm
figur
although
appear
group
higher
titer
group
neutral
antibodi
titer
also
assess
anim
termin
bleed
day
death
day
day
anim
succumb
nivm
challeng
group
consist
lower
neutral
antibodi
titer
nivm
compar
neutral
antibodi
found
anim
group
figur
signific
progress
veterinari
vaccin
one
henipaviru
hev
made
develop
effect
human
vaccin
antivir
drug
high
consequ
pathogen
niv
much
slower
complic
process
particular
restrict
infecti
niv
work
contain
hamper
progress
convent
clinic
trial
virus
niv
practic
address
develop
countermeasur
exot
pathogen
niv
fda
implement
anim
efficaci
rule
rule
specif
appli
develop
countermeasur
human
efficaci
studi
possibl
ethic
briefli
rule
permit
evalu
vaccin
therapeut
use
data
gener
studi
perform
anim
model
faith
recapitul
human
diseas
current
least
eight
anim
model
niv
includ
ifnarko
mous
model
guinea
pig
model
pig
model
cat
model
golden
syrian
hamster
model
ferret
model
two
nonhuman
primat
model
one
squirrel
monkey
african
green
monkey
model
share
least
one
aspect
seen
human
pathogenesi
contribut
vaccin
therapeut
test
two
anim
model
complet
emul
pathogenesi
seen
human
case
date
ferret
model
african
green
monkey
model
model
recapitul
seen
human
infect
sever
respiratori
neurolog
diseas
gener
vascul
base
knowledg
ferret
model
chosen
initi
evalu
vector
model
consid
initi
small
anim
screen
model
vaccin
niv
especi
sinc
recombin
sghev
protein
vaccin
shown
efficaci
ferret
african
green
monkey
sghev
vaccin
proven
util
niv
infect
two
anim
model
vaccin
regimen
requir
two
dose
use
primeboost
strategi
two
adjuv
cpg
oligodeoxynucleotid
odn
alhydrogel
includ
vaccin
formul
evalu
vector
singleinject
vaccin
lethal
nivm
challeng
ferret
nonspecif
vaccin
control
anim
group
produc
antiniv
f
antiniv
g
igg
produc
signific
neutral
antibodi
titer
nivm
thu
protect
nivminduc
diseas
display
clinic
symptom
patholog
consist
nivm
infect
viral
rna
infecti
viru
isol
system
anim
group
vaccin
gind
gener
antiniv
f
igg
possibl
crossreact
niv
g
igg
figur
neutral
antibodi
titer
nivm
protect
nivminduc
diseas
one
anim
tabl
lowgrad
fever
day
pc
similarli
ferret
group
vaccin
gind
gener
antiniv
g
igg
neutral
antibodi
titer
nivm
protect
nivminduc
diseas
use
vector
independ
gind
complement
ferret
group
vaccin
gener
antiniv
f
antiniv
g
igg
neutral
antibodi
titer
nivm
also
protect
nivminduc
diseas
observ
percent
weight
growth
less
group
figur
could
due
social
hous
anim
possibl
certain
member
cohort
compet
extra
food
anim
group
reach
percent
weight
growth
anim
group
protect
afford
group
appear
steril
viru
replic
could
detect
presenc
viral
rna
whole
blood
day
pc
detect
two
anim
per
group
versu
anim
group
tabl
mean
viru
replic
time
lower
detect
anim
group
figur
observ
antiniv
f
antibodi
circul
vaccin
ferret
interest
consid
experi
bioplex
assay
sghev
vaccin
ferret
african
green
monkey
never
detect
crossreact
nivm
f
g
vaccin
anim
one
possibl
explan
antibodi
produc
respons
nivb
g
result
format
antibodi
recogn
nivm
f
sinc
target
antigen
bioplex
assay
nivm
f
experi
sghev
vaccin
may
applic
crossreact
may
singlecycl
replic
vaccin
observ
within
scope
studi
examin
avid
antibodi
toward
nivm
f
warrant
rvsvniv
vaccin
platform
develop
difficult
determin
vaccin
platform
would
best
human
popul
deadli
pathogen
niv
import
develop
test
number
platform
combat
potenti
outbreak
prevent
vaccin
would
import
sever
popul
gener
popul
niv
outbreak
particularli
endem
area
india
bangladesh
healthcar
worker
famili
member
involv
patient
care
manag
endem
region
personnel
involv
outbreak
respons
mission
laboratori
worker
conduct
research
niv
militari
servic
personnel
suscept
use
niv
biolog
weapon
multidos
vaccin
regimen
would
feasibl
laboratori
healthcar
worker
militari
personnel
stabl
set
defin
risk
outbreak
set
case
deliber
releas
would
requir
rapidli
confer
protect
singl
administr
describ
protect
ferret
nivminduc
diseas
use
singleinject
rvsv
vaccin
vector
express
nivb
f
andor
nivb
g
protein
date
first
studi
show
efficaci
vaccin
niv
use
singl
administr
ferret
model
base
success
studi
vector
evalu
african
green
monkey
model
nivb
challeng
strain
appear
pathogen
human
rna
isol
nivb
viru
stock
nivb
obtain
patient
outbreak
bangladesh
kindli
provid
dr
thoma
ksiazek
use
approv
protocol
biosafeti
level
galveston
nation
laboratori
gnl
univers
texa
medic
branch
utmb
rna
use
make
cdna
gene
specif
primer
gene
amplifi
use
gene
specif
primer
nivb
f
g
contain
mlui
nhei
restrict
site
end
respect
pcr
amplifi
product
plasmid
restrict
digest
mlui
nhei
gel
purifi
purifi
product
vector
ligat
posit
coloni
screen
sequenc
posit
construct
rvsv
nivb
vaccin
recov
use
method
previous
describ
virus
propag
cell
transfect
pcaggsgind
express
vsv
glycoprotein
gind
titer
previous
describ
virus
complement
vsv
gind
denot
gind
g
g
make
vaccin
group
figur
vero
cell
coinfect
g
g
moi
viru
supernat
collect
hpi
titer
cell
complement
vsv
gind
nivm
obtain
patient
outbreak
malaysia
kindli
provid
dr
thoma
ksiazek
nivm
chosen
challeng
ferret
base
lethal
data
particular
stock
time
studi
viru
propag
vero
cell
eagl
minim
essenti
medium
emem
supplement
fetal
calf
serum
nivm
challeng
viru
stock
assess
presenc
endotoxin
use
test
system
pt
charl
river
wilmington
viru
prepar
dilut
limulu
amebocyt
lysat
lal
reagent
water
lrw
per
manufactur
direct
endotoxin
level
test
lal
cartridg
direct
manufactur
prepar
found
detect
limit
posit
control
show
test
valid
conduct
anim
studi
sever
restrict
number
anim
subject
volum
biolog
sampl
obtain
abil
repeat
assay
independ
thu
limit
statist
analysi
consequ
data
present
mean
calcul
replic
sampl
replic
assay
error
bar
repres
standard
deviat
across
replic
anim
studi
perform
biocontain
gnl
utmb
galveston
approv
utmb
institut
anim
care
use
committe
iacuc
anim
research
conduct
complianc
anim
welfar
act
feder
statut
regul
relat
anim
experi
involv
anim
adher
principl
state
eighth
edit
guid
care
use
laboratori
anim
nation
research
council
facil
research
conduct
fulli
accredit
associ
assess
accredit
laboratori
anim
care
intern
twenti
femal
ferret
weigh
kg
hous
group
anim
per
vaccin
group
vaccin
subject
anesthet
im
inject
ketamineacepromazinexylazin
kax
cocktail
transpond
chip
biomed
data
system
seaford
de
implant
subcutan
anim
identif
temperatur
monitor
procedur
anim
anesthet
kax
vaccin
pfu
im
inject
day
figur
anim
inocul
intranas
pfu
nivm
ml
dulbecco
minim
essenti
medium
dmem
sigmaaldrich
st
loui
mo
day
vaccin
figur
anim
anesthet
clinic
examin
includ
temperatur
respir
qualiti
blood
collect
day
pc
challeng
anim
assess
daili
weight
temperatur
score
scale
clinic
observ
base
coat
appear
social
behavior
provok
behavior
anim
score
greater
euthan
per
iacuc
protocol
subject
vaccin
cohort
euthan
studi
endpoint
day
pc
wherea
subject
group
euthan
accord
approv
human
end
point
day
pc
subject
surviv
end
studi
ferret
serum
collect
indic
time
point
test
igg
antibodi
niv
f
g
use
previous
develop
multiplex
microspher
assay
filter
plate
prime
pb
test
sera
dilut
pb
pre
vaccin
time
point
time
point
vaccin
biotinyl
goat
antiferret
igg
streptavidinphycoerythrin
strepp
also
dilut
pb
coupl
microspher
sghev
sgniv
sfhev
sfniv
prepar
sonic
minut
follow
vortex
mix
minut
dilut
pb
prime
liquid
remov
plate
use
bioplex
pro
ii
wash
station
biorad
hercul
ca
contain
coupl
microspher
ad
well
microspher
mixtur
remov
vacuum
dilut
test
sera
ad
appropri
well
incub
room
temperatur
rt
minut
shake
dark
dilut
test
sampl
remov
vacuum
dilut
biotinyl
goat
antiferret
pierc
thermoscientif
rockford
il
ad
well
incub
previous
describ
liquid
remov
vacuum
strepp
qiagen
valencia
ca
ad
well
incub
minut
liquid
remov
plate
vacuum
manifold
wash
twice
pb
remov
liquid
wash
step
final
pb
ad
well
incub
minut
describ
sampl
assay
mean
fluoresc
intens
mfi
across
least
bead
region
perform
machin
analyz
use
bioplex
manag
softwar
v
biorad
mfi
standard
deviat
sd
fluoresc
intens
across
bead
determin
sampl
plot
prnt
determin
use
convent
serum
neutral
assay
briefli
sera
serial
dilut
twofold
incub
pfu
niv
hour
viru
antibodi
ad
individu
well
plate
confluent
vero
cell
monolay
plate
stain
neutral
red
day
infect
plaqu
count
hour
stain
neutral
titer
determin
serum
dilut
reduct
plaqu
count
versu
control
well
blood
collect
place
minicollect
edta
tube
serum
tube
greiner
bio
one
monro
nc
immedi
follow
sampl
blood
ad
avl
viral
lysi
buffer
qiagen
rna
extract
tissu
approxim
mg
store
ml
rnalat
qiagen
day
stabil
rna
rnalat
complet
remov
tissu
homogen
rlt
buffer
qiagen
cryovial
use
tissu
lyser
qiagen
stainless
steel
bead
tissu
sampl
includ
right
lung
upper
lobe
right
lung
middl
lobe
right
lung
lower
lobe
left
lung
upper
lobe
left
lung
middl
lobe
left
lung
lower
lobe
liver
spleen
kidney
adren
gland
pancrea
brain
frontal
cortex
blood
sampl
inactiv
avl
viral
lysi
buffer
tissu
sampl
homogen
inactiv
rlt
buffer
prior
remov
laboratori
subsequ
rna
isol
blood
swab
use
qiaamp
viral
rna
kit
qiagen
tissu
use
rneasi
minikit
qiagen
accord
manufactur
instruct
suppli
kit
prior
studi
baselin
blood
sera
collect
via
anterior
vena
cava
ferret
day
blood
collect
anim
complet
blood
count
total
white
blood
cell
count
white
blood
cell
differenti
red
blood
cell
count
platelet
count
hematocrit
valu
total
hemoglobin
concentr
mean
cell
volum
mean
corpuscular
volum
mean
corpuscular
hemoglobin
concentr
analyz
blood
collect
minicollect
edta
tube
greiner
bio
one
use
hemavet
instrument
per
manufactur
instruct
drew
scientif
oxford
ct
serum
analysi
blood
chemistri
perform
use
vetscan
classic
analyz
comprehens
diagnost
profil
rotor
measur
albumin
alb
amylas
alanin
aminotransferas
alt
alkalin
phosphatas
alp
calcium
glucos
total
protein
total
bilirubin
tbil
blood
urea
nitrogen
bun
creatinin
cre
phosphoru
sodium
total
protein
abaxi
union
citi
ca
blood
serum
sampl
process
analyz
immedi
collect
necropsi
perform
subject
tissu
sampl
major
organ
collect
histopatholog
immunohistochem
examin
immersionfix
neutral
buffer
formalin
least
day
subsequ
formalin
chang
specimen
remov
process
convent
method
embed
paraffin
section
thick
immunohistochemistri
specif
antiniv
immunoreact
detect
use
antiniv
n
protein
rabbit
primari
antibodi
kindli
provid
dr
christoph
broder
dilut
minut
tissu
section
process
immunohistochemistri
use
dako
autostain
dako
carpinteria
ca
secondari
antibodi
use
biotinyl
goat
antirabbit
igg
vector
laboratori
burlingam
ca
minut
follow
dako
streptavidinhrp
dako
minut
slide
develop
dako
dab
chromagen
dako
minut
counterstain
hematoxylin
one
minut
nonimmun
rabbit
igg
use
neg
stain
control
rna
isol
blood
tissu
analyz
use
primersprob
target
n
gene
intergen
region
n
p
niv
quantit
realtim
pcr
qrtpcr
probe
use
cgt
cac
aca
tca
gct
ctg
acg
carboxytetramethylrhodamin
tamra
life
technolog
carlsbad
ca
niv
rna
detect
use
detect
system
biorad
onestep
probe
qrtpcr
kit
qiagen
follow
cycl
condit
minut
second
cycl
second
second
threshold
cycl
ct
valu
repres
niv
genom
analyz
cfx
manag
softwar
data
shown
genom
equival
geq
creat
geq
standard
rna
niv
challeng
stock
extract
number
niv
genom
calcul
use
avogadro
number
molecular
weight
niv
genom
viru
titrat
perform
plaqu
assay
vero
cell
serum
control
tissu
sampl
briefli
increas
dilut
sampl
adsorb
vero
cell
monolay
duplic
well
limit
detect
pfuml
author
declar
compet
interest
cem
design
vaccin
vaccin
studi
carri
anim
vaccin
infect
studi
process
anim
tissu
blood
analyz
data
draft
manuscript
kmv
clone
recov
character
propag
vaccin
process
anim
tissu
blood
particip
manuscript
prepar
rwc
carri
anim
vaccin
infect
studi
process
anim
tissu
blood
analyz
data
particip
manuscript
prepar
kna
particip
anim
infect
studi
process
anim
tissu
blood
perform
serolog
perform
viru
isol
perform
qrtpcr
analyz
data
particip
manuscript
prepar
kaf
particip
anim
infect
studi
provid
veterinari
patholog
expertis
analyz
data
particip
manuscript
prepar
maw
particip
design
vaccin
construct
studi
design
analyz
data
edit
manuscript
twg
conceiv
studi
support
work
research
fund
nation
institut
health
utmb
analyz
data
edit
manuscript
author
read
approv
final
manuscript
